FDA says its safety review of abortion pill mifepristone, which could end mail delivery, won’t finish until March, months after the Nov. 3 midterms.
FDA nominee called pill "dangerous to women"
Read the full story at NBC News
From the October 7, 2026 GovBrief, every story that day in one place.